NCT01152801
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Novartis Investigative Site Wuhan, Hubei, China
- Novartis Investigative Site Nanjing, Jiangsu, China
- Novartis Investigative Site Beijing, China
- Novartis Investigative Site Beijing, China